Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccinia as a vector for gene delivery

1 Jun 2004

Abstract excerpt

Gene therapy is a promising approach, yet so far it has shown limited effectiveness in many clinical trials, mainly due to insufficient gene transduction. Recombinant vaccinia virus (rVV) has been well developed as a gene delivery vector, initially for protein expression in mammalian cells. rVV has been further developed to express antigens in vivo in generating immunity for protection against specific infectious...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Poxvirus research and outbreaks
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15174972
DOI: 10.1517/14712598.4.6.901

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccinia as a vector for gene deliveryPMID 15174972Read ↗

Recombinant Viruses for Cancer TherapySemantic proximity Read ↗

Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer TherapiesSemantic proximity Read ↗

Immunotherapeutic potential of oncolytic vaccinia virusSemantic proximity Read ↗

Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapySemantic proximity Read ↗

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerSemantic proximity Read ↗

Exploring Reovirus Plasticity for Improving Its Use as Oncolytic VirusSemantic proximity Read ↗

Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus.Semantic proximity Read ↗

Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?Semantic proximity Read ↗

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.Semantic proximity Read ↗

Oncolytic Virotherapy for Cancer: Clinical ExperienceSemantic proximity Read ↗

Oncolytic virotherapy for cancer treatment: challenges and solutionsSemantic proximity Read ↗

Oncolytic Virotherapy: From Bench to BedsideSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.